[Carbenicillin treatment of Pseudomonas aeruginosa infections and Proteus infections in infants].
D001996:Bronchopneumonia / Q000188:drug therapy / Q000209:etiology; D002228:Carbenicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008297:Male; D010033:Otitis Media / Q000188:drug therapy / Q000209:etiology; D011511:Proteus / Q000302:isolation & purification; D011512:Proteus Infections / Q000175:diagnosis / Q000188:drug therapy*; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D011704:Pyelonephritis / Q000188:drug therapy / Q000209:etiology
D002228:Carbenicillin
Uber die Carbenicillinbehandlung von pseudomonas aeruginosa- und Proteusinfektionen im Säuglingsalter.